109062-95-5

Basic information

• Product Name: 4-Cyclohexene-1,2-dicarboxylic acid, bis[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester, (1S,2S)-
• CAS NO: 109062-95-5
• Molecular Formula: C28H46O4
• Molecular Weight: 446.671
• Mol File: 109062-95-5.mol

Chemical Properties

• CAS DataBase Reference: 4-Cyclohexene-1,2-dicarboxylic acid, bis[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester, (1S,2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Cyclohexene-1,2-dicarboxylic acid, bis[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester, (1S,2S)-(109062-95-5)
• EPA Substance Registry System: 4-Cyclohexene-1,2-dicarboxylic acid, bis[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester, (1S,2S)-(109062-95-5)

Safety Data

• Hazardous Substances Data: 109062-95-5(Hazardous Substances Data)

Upstream product

• 106-99-0 buta-1,3-diene 
• 86287-64-1 (2E,1'S,2'R,5'S)-but-2-enedioic acid bis(2'-isopropyl-5'methyl-cyclohexyl) ester 
• 15356-60-2 (1S,2R,5S)-(+)-menthol 
• 120143-40-0 (2Z,1'S,2'R,5'S)-but-2-enedioic acid bis(2'-isopropyl-5'methyl-cyclohexyl) ester 
• 34675-24-6 di-L-menthyl fumarate 
• 2216-51-5 (-)-menthol 
• 34212-60-7 di-<(1R,2S,5R)-(-)-menthyl>maleate 

Downstream Products

• 121944-09-0 (1S,2R)-1-(4,4-Dimethyl-pent-2-ynoyl)-cyclohex-4-ene-1,2-dicarboxylic acid bis-((1S,2R,5S)-2-isopropyl-5-methyl-cyclohexyl) ester 
• 479549-19-4 (1R,2R,4R,5R,1'S,2'R,5'S)-4-hydroxy-5-phenylselanyl-cyclohexane-1,2-dicarboxylic acid bis(2'-isopropyl-5'-methyl-cyclohexyl) ester 
• 956006-34-1 (1S,3R,4R,6R)-3-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyl) 4-((1S,2R,5S)-2-isopropyl-5-methylcyclohexyl) 7-oxabicyclo[4.1.0]heptane-3,4-dicarboxylate 
• 956006-35-2 (1R,2R,4R,5R)-bis((1S,2R,5S)-2-isopropyl-5-methylcyclohexyl) 4-(benzyloxy)-5-hydroxycyclohexane-1,2-dicarboxylate 
• 956006-03-4 (1R,2R,4R,5R)-bis((1S,2R,5S)-2-isopropyl-5-methylcyclohexyl) 4,5-bis(benzyloxy)cyclohexane-1,2-dicarboxylate 
• 956006-36-3 ((1R,2R,4R,5R)-4,5-bis(benzyloxy)-2-(hydroxymethyl)cyclohexyl)methanol 
• 956006-05-6 ((1R,2R,4R,5R)-4,5-bis(benzyloxy)-2-((tert-butyldimethylsilyloxy)methyl)cyclohexyl)methanol 
• 956006-37-4 ((1R,2R,4R,5R)-4,5-bis(benzyloxy)-2-(iodomethyl)cyclohexylmethoxy)(tert-butyl)dimethylsilane 
• 956006-07-8 ((1R,2R,4R,5R)-4,5-bis(benzyloxy)-2-(iodomethyl)cyclohexyl)methanol 
• 956006-11-4 (S)-3-((S)-1-((1R,2R,4R,5R)-4,5-bis(benzyloxy)-2-(hydroxymethyl)cyclohexyl)-3-(tert-butyldimethylsilyloxy)propan-2-ylamino)-4-benzyloxazolidin-2-one 
• 956006-38-5 ((1R,2R,4R,5R)-2-((S)-2-((S)-4-benzyl-2-oxozolidin-3-ylamino)-3-(tert-butyldimethylsilyloxy)propyl)-4,5-bis(benzyloxy)cyclohexyl)mehyl 4-methylbenzenesulfonate 
• 121944-10-3 (3aS,7aS)-3-tert-Butyl-1-oxo-4,7-dihydro-1H-indene-3a,7a-dicarboxylic acid bis-((1S,2R,5S)-2-isopropyl-5-methyl-cyclohexyl) ester 
• 122044-51-3 (1R,3aS,7aS)-3-tert-Butyl-1-hydroxy-4,7-dihydro-1H-indene-3a,7a-dicarboxylic acid bis-((1S,2R,5S)-2-isopropyl-5-methyl-cyclohexyl) ester 
• 58124-49-5 (5aS,9aS)-3-phenyl-1,5,5a,6,9,9a-hexahydrobenzo[e][1,3]dioxepine 

Relevant articles and documents

ADENYLYL CYCLASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF

The present invention relates to novel adenine based inhibitors of adenylyl cyclase of the formula: wherein X, L, R1, R2, R5 are those defined herein. Compounds of the present invention are useful to treat cardiovascular diseases. The present invention also relates to a method of preventing heart failure by administering an effective amount of compound according to the invention following vascular injury and reperfusion therapy.

Total synthesis of the polyenoyltetramic acid polycephalin C

The total synthesis of the polyenoyltetramic acid polycephalin C is described. Key steps of the synthesis include a double Swern oxidation, double Takai reaction and a double Stille reaction. In addition, the absolute stereochemistry of the ring junction

Conformative coupling of two conformational molecular switches

Passing on information. Two conformational switches, decalin units, were coupled to a 14-membered bislactam ring (see formula, TBDPS=tert-butyldiphenylsilyl). Removal of a bisacetal clamp on the left side of the molecule resulted in a double ring-flip of

Total synthesis of polycephalin C and determination of the absolute configurations at the 3′′,4′′ ring junction

Only through total synthesis could the absolute configuration of the 3′′R,4′′R ring junction of the polyenoltetramic acid polycephalin C (1) be unambiguously established. Key features of the synthesis include a double Swern oxidation, double Stille coupli

Synthesis and biological evaluation of a monocyclic, fully functional analogue of compactin

Compound 8, a monocyclic analogue of compactin, has been prepared and its efficacy as an inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A reductase (HMGR) evaluated. The synthesis (Schemes I and II) requires seven steps starting with di-(-)-menthyl fumar

ASYMMETRIC DIELS-ALDER REACTION. COOPERATIVE BLOCKING EFFECT IN ORGANIC SYNTHESIS

Remarkably high diastereoselectivity is observed in the organoaluminium catalyzed asymmetric Diels-Alder reaction of (-)-dimenthyl fumarate.